Huberta E. Hart

834 total citations
26 papers, 484 citations indexed

About

Huberta E. Hart is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Huberta E. Hart has authored 26 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Epidemiology and 5 papers in Economics and Econometrics. Recurrent topics in Huberta E. Hart's work include Diabetes Management and Education (8 papers), Chronic Disease Management Strategies (6 papers) and Diabetes Management and Research (6 papers). Huberta E. Hart is often cited by papers focused on Diabetes Management and Education (8 papers), Chronic Disease Management Strategies (6 papers) and Diabetes Management and Research (6 papers). Huberta E. Hart collaborates with scholars based in Netherlands, Germany and United Kingdom. Huberta E. Hart's co-authors include Guy E.H.M. Rutten, Betty Meyboom‐de Jong, Ken Redekop, Henk J.G. Bilo, Joline W. J. Beulens, Rimke C. Vos, Donald G. Grosset, D. M. Hart, David H. Barlow and Marc Berg and has published in prestigious journals such as Journal of Clinical Epidemiology, BMC Public Health and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

Huberta E. Hart

25 papers receiving 453 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Huberta E. Hart 199 84 79 56 55 26 484
Natalia Petruski‐Ivleva 97 0.5× 56 0.7× 41 0.5× 26 0.5× 148 2.7× 31 601
Lu Cheng 57 0.3× 99 1.2× 25 0.3× 23 0.4× 41 0.7× 36 562
SV Madhu 345 1.7× 117 1.4× 31 0.4× 5 0.1× 66 1.2× 73 707
Satyajeet Roy 78 0.4× 67 0.8× 15 0.2× 14 0.3× 48 0.9× 42 433
Mary Naglak 132 0.7× 36 0.4× 16 0.2× 14 0.3× 237 4.3× 24 611
Reimondo Petrocelli 52 0.3× 114 1.4× 28 0.4× 11 0.2× 27 0.5× 19 433
Han Eol Jeong 80 0.4× 55 0.7× 21 0.3× 14 0.3× 24 0.4× 56 380
Yu‐Hung Chang 187 0.9× 272 3.2× 27 0.3× 19 0.3× 154 2.8× 27 787
Benjamin J. Harshfield 122 0.6× 142 1.7× 14 0.2× 11 0.2× 332 6.0× 10 816
Negar Mortazavi 201 1.0× 92 1.1× 19 0.2× 6 0.1× 197 3.6× 22 639

Countries citing papers authored by Huberta E. Hart

Since Specialization
Citations

This map shows the geographic impact of Huberta E. Hart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huberta E. Hart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huberta E. Hart more than expected).

Fields of papers citing papers by Huberta E. Hart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huberta E. Hart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huberta E. Hart. The network helps show where Huberta E. Hart may publish in the future.

Co-authorship network of co-authors of Huberta E. Hart

This figure shows the co-authorship network connecting the top 25 collaborators of Huberta E. Hart. A scholar is included among the top collaborators of Huberta E. Hart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huberta E. Hart. Huberta E. Hart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hart, Huberta E., et al.. (2023). Evaluation of SGLT-2 inhibitor treatment in type 2 diabetes patients with very high cardiovascular risk. Primary care diabetes. 17(2). 190–194.
2.
Vos, Rimke C., et al.. (2021). Type 2 diabetes and COPD: treatment in the right healthcare setting? An observational study. BMC Family Practice. 22(1). 78–78. 1 indexed citations
3.
Akker, Ingrid Looijmans‐van den, et al.. (2020). The impact of the new Dutch guideline on cardiovascular risk management in patients with COPD: a retrospective study. BJGP Open. 5(1). bjgpopen20X101139–bjgpopen20X101139. 4 indexed citations
4.
Hart, Huberta E., Guy E.H.M. Rutten, Esther de Groot, et al.. (2019). <p>De-Intensification Of Blood Glucose Lowering Medication In People Identified As Being Over-Treated: A Mixed Methods Study</p>. Patient Preference and Adherence. Volume 13. 1775–1783. 11 indexed citations
5.
6.
Hart, Huberta E., et al.. (2017). Internet-based Self-Management Support for Patients With Well-Controlled Type 2 Diabetes: A Real-Life Study. JMIR Research Protocols. 6(3). e47–e47. 4 indexed citations
7.
Hart, Huberta E., et al.. (2016). Personalised treatment targets in type 2 diabetes patients: The Dutch approach. Primary care diabetes. 11(1). 71–77. 11 indexed citations
8.
Hart, Huberta E., et al.. (2014). Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin. Acta Diabetologica. 52(2). 383–393. 33 indexed citations
9.
Beulens, Joline W. J., et al.. (2014). Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetologica. 52(1). 47–53. 67 indexed citations
10.
Hart, Huberta E. & Guy E.H.M. Rutten. (2014). A training course for experts in diabetology in primary care. Primary care diabetes. 9(1). 68–70. 1 indexed citations
11.
Wanders, Johanna O. P., Jorien Veldwijk, G. Ardine de Wit, et al.. (2014). The effect of out-of-pocket costs and financial rewards in a discrete choice experiment: an application to lifestyle programs. BMC Public Health. 14(1). 870–870. 15 indexed citations
12.
Hart, Huberta E., Ken Redekop, Henk J.G. Bilo, Betty Meyboom‐de Jong, & Marc Berg. (2007). Health related quality of life in patients with type I diabetes mellitus: generic & disease-specific measurement.. PubMed. 125(3). 203–16. 19 indexed citations
13.
Hart, Huberta E., Ken Redekop, Henk J.G. Bilo, Marc Berg, & Betty Meyboom‐de Jong. (2005). Change in perceived health and functioning over time in patients with type I diabetes mellitus. Quality of Life Research. 14(1). 1–10. 19 indexed citations
14.
Hart, Huberta E., Ken Redekop, Marc Berg, Henk J.G. Bilo, & Betty Meyboom‐de Jong. (2005). Factors that predicted change in health-related quality of life were identified in a cohort of diabetes mellitus type 1 patients. Journal of Clinical Epidemiology. 58(11). 1158–1164. 20 indexed citations
15.
Hart, Huberta E., et al.. (2003). Quality of life of patients with type I diabetes mellitus. Quality of Life Research. 12(8). 1089–1097. 60 indexed citations
16.
Hart, Huberta E., et al.. (1999). General Practice Registration Networks in the Netherlands: A Brief Report. Journal of the American Medical Informatics Association. 6(2). 173–175. 5 indexed citations
17.
Hart, Huberta E., et al.. (1995). In vivo assessment of the atrophogenic potency of mometasone furoate, a newly developed chlorinated potent topical glucocorticoid as compared to other topical glucocorticoids old and new.. PubMed. 33(4). 187–9. 25 indexed citations
18.
Körting, Hans Christian, et al.. (1993). Anti-inflammatory activity of hamamelis distillate applied topically to the skin. European Journal of Clinical Pharmacology. 44(4). 315–318. 53 indexed citations
19.
Barlow, David H., Donald G. Grosset, Huberta E. Hart, & D. M. Hart. (1989). A study of the experience of Glasgow women in the climacteric years. BJOG An International Journal of Obstetrics & Gynaecology. 96(10). 1192–1197. 46 indexed citations
20.
Hart, Huberta E., J. Seifert, & W. Brendel. (1986). Wirkung und Nebenwirkung von Taurolin bei einer experimentellen Peritonitis der Ratte. Langenbeck s Archives of Surgery. 368(3). 149–160. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalia Petruski‐Ivleva Breakdown of academic impact, for papers by Lu Cheng Breakdown of academic impact, for papers by SV Madhu Breakdown of academic impact, for papers by Satyajeet Roy Breakdown of academic impact, for papers by Mary Naglak Breakdown of academic impact, for papers by Reimondo Petrocelli Breakdown of academic impact, for papers by Han Eol Jeong Breakdown of academic impact, for papers by Yu‐Hung Chang Breakdown of academic impact, for papers by Benjamin J. Harshfield Breakdown of academic impact, for papers by Negar Mortazavi
Rankless by CCL
2026